Profile data is unavailable for this security.
About the company
Ebos Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also an animal care products marketer and distributor. Its segments include Healthcare, Animal care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities and logistics. The Animal care segment incorporates the sale of animal care products in a range of sectors, own brands, retail and wholesale activities. Its businesses include Community Pharmacy, Institutional Healthcare, Contract Logistics and Animal Care. Community Pharmacy includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid and Intellipharm. Institutional Healthcare includes EBOS Healthcare, Onelink, Clinect and Zest. Contract Logistics comprises Healthcare Logistics, Symbion Contract Logistics and Symbion Clinical Trials. Animal Care includes Masterpet, Lyppard, Animates and Vitapet.
- Revenue in NZD (TTM)10.76bn
- Net income in NZD213.34m
- Incorporated1922
- Employees3.30k
- LocationEBOS Group Ltd108 Wrights RoadCHRISTCHURCH 8024New ZealandNZL
- Phone+64 33380999
- Fax+64 33395090
- Websitehttp://www.ebosgroup.com/
More ▼
Mergers & acquisitions
| Acquired company | EBO:NZC since announced | Transaction value |
|---|---|---|
| Pioneer Medical Ltd | 28.95% | -- |
| Sentry Medical Pty Ltd | 28.95% | 57.99m |
Data delayed at least 20 minutes, as of Jun 28 2022 01:55 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUZUKEN CO., LTD. | 26.15bn | 168.57m | 4.63bn | 15.04k | 23.38 | 0.8053 | 16.45 | 0.177 | 163.57 | 163.57 | 25,313.92 | 4,749.59 | 1.98 | 15.31 | 4.44 | -- | 1.28 | 1.75 | 3.26 | 4.59 | 7.21 | 8.21 | 0.6482 | 0.9239 | 1.07 | -- | 0.00 | 29.46 | 4.91 | 0.9754 | 82.31 | -7.55 | 2.14 | 5.92 |
| TAISHO PHARMACEUTICAL HOLDINGS Co Ltd | 3.14bn | 153.68m | 5.28bn | 9.20k | 33.07 | 0.5808 | 11.87 | 1.68 | 160.26 | 160.26 | 3,289.39 | 9,125.47 | 0.3039 | 2.29 | 5.14 | -- | 1.69 | 3.22 | 1.87 | 3.56 | 61.09 | 63.26 | 5.57 | 9.77 | 5.36 | -- | -- | 33.51 | -4.89 | -0.8411 | -1.46 | -14.54 | 10.26 | -1.89 |
| Shandong Buchang Pharmaceuticals Co Ltd | 3.69bn | 310.80m | 5.33bn | 8.35k | 16.63 | 1.47 | -- | 1.44 | 1.19 | 1.19 | 14.12 | 13.43 | 0.6656 | 1.24 | 12.45 | 1,869,074.00 | 5.35 | 8.21 | 7.58 | 11.72 | 71.95 | 79.51 | 8.03 | 11.68 | 0.7306 | 11.16 | 0.1899 | 69.67 | -1.52 | 5.05 | -30.72 | -6.13 | -8.55 | -17.73 |
| Jointown Pharmaceutical Group Co Ltd | 29.57bn | 501.22m | 5.37bn | 29.34k | 10.82 | 1.04 | -- | 0.1816 | 1.12 | 1.12 | 63.65 | 12.72 | 1.46 | 7.60 | 3.84 | 4,258,261.00 | 2.69 | 3.19 | 8.67 | 9.83 | 7.61 | 8.53 | 1.84 | 2.15 | 1.02 | 51.75 | 0.5828 | 41.35 | 10.42 | 14.74 | -17.76 | 24.34 | 3.80 | -- |
| China Medicine Health Industry Co Ltd | 8.56bn | 160.96m | 5.54bn | 8.72k | 24.60 | 1.59 | -- | 0.6474 | 0.6365 | 0.6365 | 33.86 | 9.83 | 1.11 | 4.96 | 2.95 | 4,151,740.00 | 2.29 | 5.00 | 4.91 | 11.55 | 13.88 | 16.44 | 2.06 | 3.93 | 1.28 | 6.52 | 0.3231 | 37.30 | -7.83 | 6.91 | -50.63 | -7.39 | 12.03 | -7.36 |
| China Medical System Holdings | 1.97bn | 713.32m | 6.17bn | 5.29k | 8.71 | 2.05 | 8.05 | 3.13 | 1.43 | 1.43 | 3.96 | 6.08 | 0.5849 | 4.90 | 6.82 | 1,846,330.00 | 21.22 | 19.28 | 23.87 | 21.83 | 74.93 | 72.57 | 36.29 | 34.39 | 3.32 | -- | 0.1268 | 40.07 | 20.03 | 11.21 | 19.25 | 17.01 | 23.23 | 16.47 |
| Aurobindo Pharma Ltd | 4.75bn | 535.78m | 6.24bn | 19.36k | 11.65 | 1.26 | 8.18 | 1.32 | 45.19 | 45.19 | 400.27 | 419.43 | 0.6922 | 1.22 | 6.24 | -- | 7.81 | 11.53 | 10.81 | 18.30 | 56.77 | 54.80 | 11.29 | 14.54 | 1.30 | 328.32 | 0.104 | 7.88 | -5.32 | 9.22 | -50.36 | 2.84 | 9.81 | 29.20 |
| China Resources Pharmaceutical Group Ltd | 47.77bn | 760.25m | 6.82bn | 65.00k | 8.97 | 0.663 | 3.57 | 0.1427 | 0.5999 | 0.5999 | 37.69 | 8.11 | 1.03 | 7.42 | 3.79 | 3,643,172.00 | 2.90 | 3.40 | 11.42 | 12.03 | 14.94 | 16.43 | 2.81 | 3.14 | 1.04 | 6.69 | 0.3732 | 21.87 | 18.15 | 8.61 | 14.31 | 5.96 | 10.58 | 10.76 |
| EBOS Group Ltd | 10.76bn | 213.34m | 7.52bn | 3.30k | 30.71 | 3.19 | 25.54 | 0.6984 | 1.29 | 1.29 | 65.20 | 12.42 | 2.29 | 10.69 | 8.25 | -- | 4.50 | 4.54 | 8.23 | 8.78 | 10.93 | 10.74 | 1.97 | 1.91 | 0.9165 | 16.11 | 0.202 | 74.46 | 4.99 | 7.15 | 14.02 | 9.72 | 38.46 | 8.96 |
| Kobayashi Pharmaceutical Co Ltd | 1.85bn | 229.09m | 8.02bn | 3.45k | 33.29 | 3.35 | 27.97 | 4.35 | 250.80 | 250.80 | 2,022.51 | 2,489.23 | 0.6618 | 3.79 | 3.88 | 45,676,320.00 | 8.21 | 8.02 | 10.04 | 10.39 | 56.86 | 58.81 | 12.41 | 11.66 | 3.39 | -- | 0.0032 | 30.44 | 3.15 | -- | 2.66 | -- | -- | -- |
Data as of Jun 28 2022. Currency figures normalised to EBOS Group Ltd's reporting currency: New Zealand Dollar NZD
14.73%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harbour Asset Management Ltd.as of 01 Sep 2021 | 5.32m | 2.81% |
| Accident Compensation Corp.as of 16 Jul 2021 | 4.91m | 2.59% |
| Fidelity Management & Research Co. LLCas of 08 Dec 2020 | 4.19m | 2.21% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 2.88m | 1.52% |
| Guardians of New Zealand Superannuationas of 30 Jun 2021 | 2.78m | 1.47% |
| The Vanguard Group, Inc.as of 02 Jun 2022 | 2.60m | 1.37% |
| FMR Investment Management (UK) Ltd.as of 08 Dec 2020 | 2.41m | 1.27% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2022 | 1.02m | 0.54% |
| Fidelity Management & Research (Japan) Ltd.as of 08 Dec 2020 | 917.01k | 0.48% |
| Dimensional Fund Advisors LPas of 02 Jun 2022 | 867.24k | 0.46% |
More ▼
Data from 30 Jun 2021 - 22 Jun 2022Source: FactSet Research Systems Inc.
